InMed Pharmaceuticals Inc.INMNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank27
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-8.69M
Near historical average
Percentile
P27
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
$-8.53M
Historical baseline
PeriodValueYoY Change
TTM$-8.69M-19.8%
2025$-7.26M-2.7%
2024$-7.06M+9.2%
2023$-7.78M+41.4%
2022$-13.28M-9.1%
2021$-12.17M-39.0%
2020$-8.76M+14.7%
2019$-10.26M-53.5%
2018$-6.69M-98.7%
2017$-3.36M-